• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Chemotherapy for advanced non-small-cell lung cancer.

作者信息

Walling J

机构信息

Medical Department, Lilly Industries Ltd, Hants, U.K.

出版信息

Respir Med. 1994 Oct;88(9):649-57. doi: 10.1016/s0954-6111(05)80061-7.

DOI:10.1016/s0954-6111(05)80061-7
PMID:7528933
Abstract
摘要

相似文献

1
Chemotherapy for advanced non-small-cell lung cancer.
Respir Med. 1994 Oct;88(9):649-57. doi: 10.1016/s0954-6111(05)80061-7.
2
Chemotherapy for advanced non-small cell lung cancer.
Hematol Oncol Clin North Am. 1997 Jun;11(3):473-517. doi: 10.1016/s0889-8588(05)70445-7.
3
Alternative strategy to achieve increased overall survival and better quality of life in patients with second-line advanced non-small-cell lung cancer.
J Clin Oncol. 2015 Feb 10;33(5):522-3. doi: 10.1200/JCO.2014.58.1603. Epub 2015 Jan 12.
4
Chemotherapy for lung cancer.
N Engl J Med. 2002 May 9;346(19):1498; author reply 1498. doi: 10.1056/NEJM200205093461914.
5
Chemotherapy of advanced non-small cell lung cancer: any standard treatment?
Lung Cancer. 2002 Jul;37(1):15-6. doi: 10.1016/s0169-5002(02)00032-6.
6
Outcomes of palliative chemotherapy in stage IV non-small cell lung cancer. Have we found what we are looking for?
Lung Cancer. 2004 Mar;43(3):373-4. doi: 10.1016/j.lungcan.2003.08.032.
7
Palliative chemotherapy for non-small cell lung cancer: a measured dose of reality.非小细胞肺癌的姑息化疗：对现实情况的审慎考量
J Support Oncol. 2007 Jan;5(1):27-8.
8
Palliative benefits of chemotherapy treatment in non-small cell lung cancer may be underappreciated.
J Support Oncol. 2006 Feb;4(2):61.
9
Maintenance Therapy Improves Survival Outcomes in Patients with Advanced Non-small Cell Lung Cancer.维持治疗可改善晚期非小细胞肺癌患者的生存结局。
Lung. 2015 Dec;193(6):1057. doi: 10.1007/s00408-015-9816-5. Epub 2015 Oct 6.
10
Can a single pill replace doublet chemotherapy in first-line therapy of advanced non-small cell lung cancer?
Clin Cancer Res. 2006 Oct 15;12(20 Pt 1):5919-20. doi: 10.1158/1078-0432.CCR-06-1553.

引用本文的文献

1
Survival Analysis and Clinical Outcomes between Paclitaxel and Carboplatin Versus Carboplatin and Gemcitabine in Patients with Advanced-stage Non-small-cell Lung Cancer: A Single-center Cohort Study.紫杉醇联合卡铂与卡铂联合吉西他滨治疗晚期非小细胞肺癌患者的生存分析和临床结局：一项单中心队列研究。
Asian Pac J Cancer Prev. 2022 Oct 1;23(10):3371-3378. doi: 10.31557/APJCP.2022.23.10.3371.
2
Serum Protein Pattern Could Predict the Therapeutic Effect of First-Line Pemetrexed/Cisplatin Chemotherapy in Patients With Lung Adenocarcinoma.血清蛋白谱可预测肺腺癌患者一线培美曲塞/顺铂化疗的疗效。
World J Oncol. 2015 Feb;6(1):292-296. doi: 10.14740/wjon901w. Epub 2015 Feb 14.
3
A Case of Multifocal Skin Metastases from Lung Cancer Presenting with Vasculitic-type Cutaneous Nodule.
一例以血管炎型皮肤结节为表现的肺癌多灶性皮肤转移病例。
Indian J Dermatol. 2015 Mar-Apr;60(2):213. doi: 10.4103/0019-5154.152582.
4
Prophylactic cranial irradiation may impose a detrimental effect on overall survival of patients with nonsmall cell lung cancer: a systematic review and meta-analysis.预防性颅脑照射可能对非小细胞肺癌患者的总生存期产生不利影响：一项系统评价和荟萃分析。
PLoS One. 2014 Jul 29;9(7):e103431. doi: 10.1371/journal.pone.0103431. eCollection 2014.
5
Critical appraisal of pemetrexed in the treatment of NSCLC and metastatic pulmonary nodules.培美曲塞治疗非小细胞肺癌和转移性肺结节的批判性评价。
Onco Targets Ther. 2014 Jun 6;7:937-45. doi: 10.2147/OTT.S45148. eCollection 2014.
6
Non-platinum doublets were as effective as platinum-based doublets for chemotherapy-naïve advanced non-small-cell lung cancer in the era of third-generation agents.在三代药物时代，对于化疗初治的晚期非小细胞肺癌，非铂类双药与基于铂类的双药同样有效。
J Cancer Res Clin Oncol. 2013 Jan;139(1):25-38. doi: 10.1007/s00432-012-1294-z. Epub 2012 Aug 5.
7
Pemetrexed plus platinum as the first-line treatment option for advanced non-small cell lung cancer: a meta-analysis of randomized controlled trials.培美曲塞联合铂类作为晚期非小细胞肺癌一线治疗选择：一项随机对照试验的荟萃分析。
PLoS One. 2012;7(5):e37229. doi: 10.1371/journal.pone.0037229. Epub 2012 May 17.
8
Evaluation of the Reliability of Electronic Medical Record Data in Identifying Comorbid Conditions among Patients with Advanced Non-Small Cell Lung Cancer.评估电子病历数据在识别晚期非小细胞肺癌患者合并症方面的可靠性
J Cancer Epidemiol. 2011;2011:983271. doi: 10.1155/2011/983271. Epub 2011 May 2.
9
Pemetrexed as first-line therapy for non-squamous non-small cell lung cancer.培美曲塞作为非鳞状非小细胞肺癌的一线治疗药物。
Ther Clin Risk Manag. 2009;5:781-7. doi: 10.2147/tcrm.s3195. Epub 2009 Oct 12.
10
Pemetrexed single agent chemotherapy in previously treated patients with locally advanced or metastatic non-small cell lung cancer.培美曲塞单药化疗用于既往接受过治疗的局部晚期或转移性非小细胞肺癌患者。
BMC Cancer. 2008 Jul 31;8:216. doi: 10.1186/1471-2407-8-216.